# OnCo record medicare-ncd-190-7 (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/medicare-ncd-190-7/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "medicare-ncd-190-7" ;
  schema:name "Medicare NCD 190.7: human tumour stem cell drug sensitivity assays"@en ;
  schema:alternateName "NCD 190.7"@en, "Human Tumor Stem Cell Drug Sensitivity Assays"@en, "chemosensitivity assay coverage"@en ;
  schema:description "Medicare treats laboratory tests that grow a patient's tumour cells and expose them to cancer drugs to pick a treatment as experimental, and does not pay for them."@en ;
  schema:url <https://onco.cc/terms/medicare-ncd-190-7/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=253&ncdver=1>, <https://api.coverage.cms.gov/v1/data/ncd?ncdid=253&ncdver=1> ;
  onco:tag "us" ;
  onco:related <https://onco.cc/technologies/functional-precision-medicine-haematology/> ;
  onco:institutions <https://onco.cc/institutions/cms/> ;
  onco:terms <https://onco.cc/terms/drug-response-sensitivity/> .